Skip Over Navigation Links
National Institutes of Health
:
Find more NIMH pages about: Clinical Research and Trials

Science News about Clinical Research And Trials

Find Press Releases and Science Updates by Topic

Intermittent Explosive Disorder Affects up to 16 Million Americans
June 5, 2006 • Press Release
A little-known mental disorder marked by episodes of unwarranted anger is more common than previously thought, a study funded by NIMH has found.
Depression Rates Are Lower in Children Whose Mothers Are Successfully Treated
May 9, 2006 • Science Update
When women treated for depression become symptom-free, their children are less likely to be diagnosed with depression, according to a study published in the March 22/29 issue of the Journal of the American Medical Association.
Studies Offer New Information About Treatment Choices for Schizophrenia — Phase 2 Results
April 1, 2006 • Science Update
A national clinical trial comparing clozapine with other new-generation antipsychotic medications for the treatment of chronic schizophrenia has shown that people who switched to clozapine from their first medication because it failed to manage symptoms adequately were twice as likely to continue treatment as patients who switched to other antipsychotic medications.
New Strategies Help Depressed Patients Become Symptom-Free
March 23, 2006 • Press Release
Results of the nation’s largest depression study show that one in three depressed patients who previously did not achieve remission using an antidepressant became symptom-free with the help of an additional medication and one in four achieved remission after switching to a different antidepressant.
Gene Influences Antidepressant Response
March 15, 2006 • Press Release
Whether depressed patients will respond to an antidepressant depends, in part, on which version of a gene they inherit, a study led by scientists at NIH has discovered. Having two copies of one version of a gene that codes for a component of the brain’s mood―regulating system increased the odds of a favorable response to an antidepressant by up to 18 percent, compared to having two copies of the other, more common version.
Early Findings from Largest NIMH-Funded Research Program on Bipolar Disorder Begin to Build Evidence-Base on Best Treatment Options
February 1, 2006 • Science Update
Findings from an NIMH research program on bipolar disorder provide much needed long-term data on the chronic, recurrent course of the disorder, and begin the work of building an evidence-base on the best treatments for those with the disorder.
Initial Results Help Clinicians Identify Patients with Treatment-Resistant Depression
January 1, 2006 • Press Release
Initial results of the nation’s largest clinical trial for depression have helped clinicians to track “real world” patients who became symptom-free and to identify those who were resistant to the initial treatment.
NIMH Study To Guide Treatment Choices for Schizophrenia (Phase 1 Results)
September 19, 2005 • Press Release
A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications
Combination Treatment Most Effective in Adolescents with Depression
August 17, 2004 • Press Release
A clinical trial of 439 adolescents with major depression has found a combination of medication and psychotherapy to be the most effective treatment.
Gene More Than Doubles Risk Of Depression Following Life Stresses
July 17, 2003 • Press Release
Among people who suffered multiple stressful life events over 5 years, 43 percent with one version of a gene developed depression, compared to only 17 percent with another version of the gene, say researchers funded, in part, by the National Institute of Mental Health (NIMH).
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next >